160 related articles for article (PubMed ID: 35967322)
1. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract][Full Text] [Related]
2. 92R Monoclonal Antibody Inhibits Human CCR9
Somovilla-Crespo B; Martín Monzón MT; Vela M; Corraliza-Gorjón I; Santamaria S; Garcia-Sanz JA; Kremer L
Front Immunol; 2018; 9():77. PubMed ID: 29434597
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.
Chamorro S; Vela M; Franco-Villanueva A; Carramolino L; Gutiérrez J; Gómez L; Lozano M; Salvador B; García-Gallo M; Martínez-A C; Kremer L
MAbs; 2014; 6(4):1000-12. PubMed ID: 24870448
[TBL] [Abstract][Full Text] [Related]
4. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
5. LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability.
Zeng X; Lei Y; Pan S; Sun J; He H; Xiao D; Jamal M; Shen H; Zhou F; Shao L; Zhang Q
J Leukoc Biol; 2023 Feb; 113(2):203-215. PubMed ID: 36822174
[TBL] [Abstract][Full Text] [Related]
6. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
7. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
8. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
[No Abstract] [Full Text] [Related]
9. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
10. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
[TBL] [Abstract][Full Text] [Related]
11. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry.
Nanamiya R; Takei J; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Hosono H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Jun; 40(3):101-106. PubMed ID: 34161159
[TBL] [Abstract][Full Text] [Related]
12. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
Wermers JD; McNamee EN; Wurbel MA; Jedlicka P; Rivera-Nieves J
Gastroenterology; 2011 May; 140(5):1526-35.e3. PubMed ID: 21300065
[TBL] [Abstract][Full Text] [Related]
14. PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.
Schroder PM; Khattar M; Baum CE; Miyahara Y; Chen W; Vyas R; Muralidharan S; Mierzejewska B; Stepkowski SM
Diabetologia; 2015 Jun; 58(6):1309-18. PubMed ID: 25794782
[TBL] [Abstract][Full Text] [Related]
15. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
16. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine receptor 7 and 9 double-deficient hematopoietic progenitors are severely impaired in seeding the adult thymus.
Krueger A; Willenzon S; Lyszkiewicz M; Kremmer E; Förster R
Blood; 2010 Mar; 115(10):1906-12. PubMed ID: 20040757
[TBL] [Abstract][Full Text] [Related]
19. Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C
Kobayashi H; Asano T; Tanaka T; Suzuki H; Kaneko MK; Kato Y
Antibodies (Basel); 2023 Jan; 12(1):. PubMed ID: 36810516
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6-mediated CCR9
Ma F; Li S; Gao X; Zhou J; Zhu X; Wang D; Cai Y; Li F; Yang Q; Gu X; Ge W; Liu H; Xiao X; Hao H
EBioMedicine; 2019 Jun; 44():71-85. PubMed ID: 31129099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
